• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Neurology

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

byPaary BalakumarandSimon Pan
April 24, 2026
in Neurology, Pharma
Reading Time: 2 mins read
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Share on FacebookShare on Twitter

1. Tenecteplase (TNKase) improved early recanalization and short-term neurologic recovery, but in patients older than 80 years with minor ischemic stroke, it did not improve and may worsen 90-day functional outcomes.

2. In this older subgroup, tenecteplase was associated with more serious adverse events, especially hemorrhagic complications and stroke progression or recurrence, supporting standard care over thrombolysis in this setting.

Evidence Rating Level: 1 (Excellent) 

This post hoc age-stratified analysis of the TEMPO-2 randomized trial examined whether intravenous tenecteplase benefits older adults with minor ischemic stroke, a group for whom high-quality thrombolysis data remain limited. TEMPO-2 enrolled adults with minor deficits, baseline independence, and symptomatic intracranial occlusion or focal perfusion lesion within 12 hours of symptom onset, and compared tenecteplase 0.25 mg/kg with non-thrombolytic standard care. The primary outcome was a 90-day modified Rankin Scale responder analysis, and secondary outcomes included 90-day function and quality of life, early neurologic recovery, recanalization, and adverse events. Among 884 patients, 208 were older than 80 years. In this subgroup, tenecteplase was associated with worse functional outcomes, including lower rates of mRS 0–1 at 90 days compared with standard care (46.2% vs 59.8%; adjusted risk ratio 0.83, 95% CI 0.72–0.97). Although tenecteplase improved early vessel recanalization and short-term neurologic recovery in both older and younger patients, these early gains did not translate into better 90-day outcomes in those older than 80 years. Serious adverse events were also more frequent in the older tenecteplase group, particularly hemorrhagic events and stroke progression or recurrence. Overall, these findings do not support routine thrombolysis with tenecteplase for minor stroke in patients older than 80 years.

Click here to read the study in Neurology

Image: PD

RELATED REPORTS

First messenger RNA influenza vaccine outperforms standard-dose vaccination

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Brain-predicted age difference may reliably predict dementia progression

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: acute ischemic strokeneurologyolder adultstenecteplase
Previous Post

Jennifer Aniston’s “Strength for 50+” ritual spotlights red light therapy

Next Post

2 Minute Medicine Rewind April 27, 2026

RelatedReports

Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Next Post
Development of a risk index for colorectal cancer screening

2 Minute Medicine Rewind April 27, 2026

Adolescent mothers in protective care more likely to have their children placed in care

Early child-rearing conditions may improve psychosocial outcomes in adopted children compared to unadopted biological siblings

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

The American Lung Association issues respiratory warning over viral "mouth taping" fad

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
  • The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.